Vaginal progesterone for the prevention of recurrent spontaneous preterm birth-Reference-Cited by-同舟云学术

Vaginal progesterone for the prevention of recurrent spontaneous preterm birth

Published:2023-10 Issue:10 Volume:5 Page:101116
ISSN:2589-9333
Container-title:American Journal of Obstetrics & Gynecology MFM
language:en
Short-container-title:American Journal of Obstetrics & Gynecology MFM

Author:

Berghella Vincenzo,Gulersen Moti,Roman Amanda,Boelig Rupsa C.

Funder

Covis Pharma

Publisher

Elsevier BV

Subject

General Medicine,Obstetrics and Gynecology

Reference46 articles.

1. ACOG statement on the FDA withdrawal of 17-OHPC. American College of Obstetricians and Gynecologists. 2023. Available at:https://www.acog.org/news/news-releases/2023/04/acog-statement-on-the-fda-withdrawal-of-17-ohpc. Accessed May 30, 2023.

2. SMFM Publications Committee. Society for Maternal-Fetal Medicine Statement: response to the Food and Drug Administration's withdrawal of 17-alpha hydroxyprogesterone caproate;Am J Obstet Gynecol,2023

3. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate;Meis;N Engl J Med,2003

4. Population pharmacokinetics of 17α-hydroxyprogesterone caproate in singleton gestation;Sharma;Br J Clin Pharmacol,2016

5. Pharmacology and placental transport of 17-hydroxyprogesterone caproate in singleton gestation;Caritis;Am J Obstet Gynecol,2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaginal progesterone should be offered to patients with a singleton gestation and a history of spontaneous preterm birth only if a cervical length ≤25 mm is detected at midtrimester;American Journal of Obstetrics & Gynecology MFM;2024-01

2. Development and validation of a nomogram to predict spontaneous preterm birth in singleton gestation with short cervix and no history of spontaneous preterm birth;Heliyon;2023-10